ArticleNPJ vaccines2022

A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles.

Ryoma Nakao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.